In glutaric aciduria type I, an autosomal recessive disease of mitochondrial lysine, hydroxylysine and tryptophan catabolism, striatal lesions are characteristically induced by acute encephalopathic crises during a finite period of brain development (age 3-36 months). The frequency of striatal injury is significantly less in patients diagnosed as asymptomatic newborns by newborn screening. Most previous studies have focused on the onset and mechanism of striatal injury, whereas little is known about neuroradiological abnormalities in pre-symptomatically diagnosed patients and about dynamic changes of extrastriatal abnormalities. Thus, the major aim of the present retrospective study was to improve our understanding of striatal and extrastriatal abnormalities in affected individuals including those diagnosed by newborn screening. To this end, we systematically analysed magnetic resonance imagings (MRIs) in 38 patients with glutaric aciduria type I diagnosed before or after the manifestation of neurological symptoms. To identify brain regions that are susceptible to cerebral injury during acute encephalopathic crises, we compared the frequency of magnetic resonance abnormalities in patients with and without such crises. Major specific changes after encephalopathic crises were found in the putamen (P50.001), nucleus caudatus (P50.001), globus pallidus (P = 0.012) and ventricles (P = 0.001). Analysis of empirical cumulative distribution frequencies, however, demonstrated that isolated pallidal abnormalities did not significantly differ over time in both groups (P = 0.544) suggesting that isolated pallidal abnormalities are not induced by acute crises--in contrast to striatal abnormalities. The manifestation of motor disability was associated with signal abnormalities in putamen, caudate, pallidum and ventricles. In addition, we found a large number of extrastriatal abnormalities in patients with and without preceding encephalophatic crises. These abnormalities include widening of anterior temporal and sylvian CSF spaces, pseudocysts, signal changes of substantia nigra, nucleus dentatus, thalamus, tractus tegmentalis centralis and supratentorial white matter as well as signs of delayed maturation (myelination and gyral pattern). In contrast to the striatum, extrastriatal abnormalities were variable and could regress or even normalize with time. This includes widening of sylvian fissures, delayed maturation, pallidal signal changes and pseudocysts. Based on these results, we hypothesize that neuroradiological abnormalities and neurological symptoms in glutaric aciduria type I can be explained by overlaying episodes of cerebral alterations including maturational delay of the brain in utero, acute striatal injury during a vulnerable period in infancy and chronic progressive changes that may continue lifelong. This may have widespread consequences for the pathophysiological understanding of this disease, long-term outcomes and therapeutic considerations.
Introduction
Glutaric aciduria type I is a rare cerebral organic aciduria caused by inherited deficiency of glutaryl-CoA dehydrogenase. The disease has an estimated prevalence of 1 in 100 000 newborns (Kö lker et al., 2007a) ; more than 150 GCDH gene mutations are known (Goodman et al., 1998; Zschocke et al., 2000) . Biochemically, accumulation of glutaric acid, 3-hydroxyglutaric acid and glutarylcarnitine is found. Two arbitrary biochemical subgroups, low and high excretors, have been described (Baric et al., 1999) . Past studies, however, have not identified any correlation between the biochemical and clinical phenotype Kö lker et al., 2006) . Untreated, most patients develop an acute encephalopathic crisis during a finite period (age 3-36 months) of brain development resulting in acute striatal injury and, subsequently, dystonia (Kö lker et al., 2006) . Some patients may develop spasticity or akinetic-rigid parkinsonism in addition (Kyllerman et al., 2004; Gitiaux et al., 2008) . A few patients have developed neurologic disease without encephalopathic crisis. These variants have been termed insidious-onset (Hoffmann et al., 1996) and late-onset type (Bä hr et al., 2002) , however, there is no accepted classification. In pre-symptomatically diagnosed children, the combination of a low-lysine diet and L-carnitine supplementation, with an intensified emergency treatment during intercurrent illness has significantly improved the outcome (Monavari and Naughten, 2000; Kö lker et al., 2007a) . Consequently, newborn screening for glutaric aciduria type I has been implemented in some countries (Chace et al., 2003; Lindner et al., 2006; Bijarnia et al., 2008) .
Neuroradiological studies have primarily focused on striatal abnormalities (Brismar and Ozand, 1995; Desai et al., 2003; Elster, 2004; Oguz et al., 2005; Strauss et al., 2007; Gitiaux et al., 2008) , whereas lesions in other deep grey matter nuclei have been described only sporadically (Twomey et al., 2003) . In addition, alterations of the frontotemporal CSF spaces have commonly been observed. They consist of enlarged anterior temporal CSF spaces, incomplete opercularization and widening of sylvian fissures and are variably described as temporal hypoplasia, frontotemporal atrophy or 'batwing' appearance. Notably, widening of sylvian fissures and frontotemporal atrophy are already present at the time of birth in preterm and term babies with glutaric aciduria type I and even during the last trimester of pregnancy (Forstner et al., 1999; Lin et al., 2002) . Patients with late-onset neurologic disease predominantly present with white matter abnormalities (Kü lkens et al., 2005) . However, little is known about magnetic resonance imaging (MRI) in pre-symptomatically diagnosed patients, about extrastriatal abnormalities and the implication of MRI changes for the neurological presentation.
Patients and Methods

Patient groups and evaluation of cranial MRIs
Metabolic centres which have contributed to previous clinical studies (Kö lker et al., 2006 (Kö lker et al., , 2007a provided digitalized cranial MRIs of study patients. Cranial MRIs were sent to the study centre (SK, SFG, GFH: University Children's Hospital, Heidelberg, Germany), and, subsequently, were evaluated independently by three neuroradiologists (IH, ENP and AS) using a standardized protocol (Supplementary Table 1 ). Brain maturation stage was assessed according to myelination and gyration time tables (Barkovich, 2000; Van der Knaap and Valk, 2005) . Signal alterations were rated as white matter abnormality if (i) they did not correspond to the normal pattern of myelinated and unmyelinated structures of a younger child; and/or (ii) the signal changes were more prominent than the signal of as yet unmyelinated white matter. They were not rated as abnormal if they were restricted to the parieto-occipital white matter, since these might well correspond to the normal 'terminal zones of myelination'. Retrospective neuroradiological assessment was made without knowledge of the disease course, the mode of diagnosis, treatment or any other relevant clinical information that might have influenced objectivity.
Sixty-eight cranial MRI studies consisting of at least T 2 -and T 1 -weighted sequences were performed between the ages of 9 days and 66 years (median age: 15 months) in 38 patients (18 female, 20 male). The majority of these patients were neurologically asymptomatic at the time of MRI (n = 21 patients), while 17 patients underwent MRI after the onset of neurological symptoms. In acutely injured patients, MRI was performed at least 1 week after the acute onset of neurologic symptoms, i.e. the chronic stage according to a recent definition (Strauss et al., 2007) . One pre-symptomatically diagnosed patient with a subsequent crisis was only imaged before, but not after this crisis.
Patient information
For all patients, detailed information on birth date, diagnosis, gender, mutation analysis and/or enzyme analysis, organic acid analysis, clinical presentation, anthropometrics and neurodevelopment were reported as described (Kö lker et al., 2007a) . Age-adapted maintenance and emergency treatment protocols of study patients were in agreement with a recently published guideline for glutaric aciduria type I (Kö lker et al., 2007b); these protocols having been used by contributing metabolic centres from Germany and some other countries at least since 1993.
To estimate the severity of neurological disease, we determined the handicap score and the morbidity score as previously described (Kö lker et al., 2006) . In brief, the handicap score is based on the overall estimation of motor disability by caring physicians [0 = unaffected; 1 = mild (mild-motor dysfunction without disability in daily life); 2 = moderate (moderate dysfunction causing some but no limiting disability); 3 = severe (limiting disability with few motor skills left); and 4 = very severe (loss of motor skills except voluntary eye movements)]. Morbidity score adds one point each for loss of mobility, feeding problems, respiratory problems and seizures, ranging from 0 (asymptomatic) to 4 (multiple morbidity). The manifestation of dystonia (0 = no; 1 = yes) was also included in the analysis. In addition, standardized psychological tests [Bayley Scales of Infant Development, second edition (BSID-II); Snijders-Oomen Non-verbal Intelligence Test, revised version (SON-R); Hamburg Wechsler Intelligence Test for children, third edition, German version (HAWIK-III) and Hannover Wechsler Intelligence Test for pre-school children, third edition, German version (HAWIVA-III)] were performed in some patients.
Patients were anonymized by initials, birth date and gender, and double entries were excluded by these parameters. Data were only included if written informed consent was obtained from patients and/or parents. No patient declined inclusion into this study. Patients with unconfirmed diagnosis were excluded. The study was approved by the Institutional Ethics Committee of the University of Heidelberg (# 314/2002) .
Statistical analysis
Statistical analysis was performed using R (R Development Core Team, 2008) . To evaluate the frequency of MRI abnormalities in specific brain regions, we calculated the region-specific percentage of pathological changes. To estimate the impact of acute encephalopathic crises on MRI changes, we subdivided neuroradiological results for patients with and without reported crises. Region-specific differences between these groups were analysed using Fisher's exact test. To prevent bias by variant disease forms, we performed this analysis twice: once excluding the five patients with suggested variant disease forms (insidious-onset: n = 1; late onset: n = 4), and again including these patients in the group without encephalopathic crises.
With regard to the age dependence of specific MRI changes, differences in time points and frequency of MRI studies had to be taken into consideration. We calculated the empirical cumulative distribution function of age-dependent changes assuming that longitudinal changes in each patient are due to the same mechanism and that therapeutic effectiveness and adherence to treatment were the same for all study patients. Results of the MRI evaluation were used in a dichotomized way considering the presence or absence of MRI abnormalities but not their gradual intensity. Subsequently, differences of age-dependent MRI abnormalities between patients with and without acute encephalopathic crises were analysed using the Peto and Peto modifications of the Wilcoxon Gehan test for left-censored data (Harrington and Fleming, 1982; Helsel, 2005) . Data were leftcensored for MRI abnormalities, because brain abnormalities develop during a variable time before diagnosis by MRI. If more than one MRI of a single study patient was included, statistical analysis considered only the MRI, which first described a specific pathology.
To investigate the relation between MRI abnormalities and neurological signs, we used the Kruskal-Wallis test and subsequent Benjamini-Hochberg correction of P-values (Benjamini and Hochberg, 1995) .
Results
Exemplified follow-up investigations of five patients without striatal injury Case reports of four neonatally diagnosed children and of one child with suggested late-onset disease variant are presented prior to the analysis of study results. We hereby aim to highlight the variability of MRI abnormalities and neurological presentation in patients without acute striatal injury.
Case 1: Progressive extrastriatal abnormalities accompanied by mild-mental retardation A macrocephalic boy of consanguineous Turkish parents born at term was diagnosed by newborn mass screening in Germany (Patient #25, Table 1 ). He is homozygous for E365K in the GCDH gene and has 1% residual enzyme activity. Treatment with low-lysine diet and carnitine was started at age 10 days, however, intermittent episodes of increased lysine intake and irregular carnitine supplementation were reported by his parents. These episodes were paralleled by transiently decreased plasma carnitine concentrations and increased urinary glutaric acid and 3-hydroxyglutaric acid concentrations ( Supplementary Fig. 1A ). During the first 2 years of life he was admitted to hospital five times for the initiation of emergency treatment. Encephalopathic crises were prevented, although twice the start of emergency treatment was delayed for 424 h. He has not developed a movement disorder and was able to sit independently at 6 months, to stand at 12 months and to walk at 15 months of age. He speaks German and Turkish fluently. Psychological testing revealed mild-mental retardation using BSID-II (mental developmental index at ages 12 and 26 months: 78 and 58) and SON-R (IQ at ages 47 and 55 months: 57 and 53, respectively).
Cranial MRI was performed at ages 5, 12 and 26 months. MRI revealed severe, symmetrical widening of anterior CSF spaces and sylvian fissures as well as progressive grey matter abnormalities, namely of globus pallidus, thalamus, dentate nucleus and very discretely of the substantia nigra. White matter involvement consisted of delayed myelination at 26 months and T 2 hyperintensity of periventricular and lobar white matter and central tegmental tracts (Fig. 1) . Fig. 1B ). Serial MRI was obtained at ages 0.5, 12, 25, 40 and 50 months. They document normalization of initially widened anterior temporal CSF spaces and sylvian fissures, completion of earlier delayed myelination, slow evolution of white matter abnormalities and significant regression of the initial pallidal T 2 hyperintensity ( Fig. 2 and Supplementary Fig. 2 ).
Case 3: Resolution of frontotemporal hypoplasia and pseudocysts
A boy of non-consanginuous German parents born at term was diagnosed by newborn screening (Patient #37). Molecular genetics revealed only a single mutation at one allele (R313W) but enzyme analysis confirmed the diagnosis (1% residual enzyme activity). Treatment was started on postnatal Day 8. During the first 2 years of life, he was admitted to hospital for emergency treatment once. His motor development was normal (sitting: 6 months, standing: 11 months, walking: 16 months). Psychological testing confirmed normal motor and mental development (BSID-II: mental developmental index at ages 13 and 24 months: 97 and 90; HAWIVA-III: IQ at age 47 months: 95). He is now 4 years of age and speaks German fluently. To our knowledge, he has never developed secondary carnitine depletion. Urinary excretion of glutaric acid and 3-hydroxyglutaric acid has remained low during treatment ( Supplementary Fig. 1C ).
Serial MRI was performed at ages 0.5, 6, 13, 25 and 36 months. The initial examination revealed an immature pattern of gyration and myelination, normally observed at 34-35 weeks postconceptional age, in combination with subependymal pseudocysts and wide anterior temporal and sylvian CSF spaces. The follow-up scans document retarded, but ultimately completed myelination, resolution of subependymal pseudocysts and normalization of CSF spaces. These serial MRI images highlight that extrastriatal abnormalities may regress in patients with glutaric aciduria type I (Fig. 3 ).
Case 4: Evolving white matter abnormalities, cortical and cerebellar atrophy A macrocephalic boy of non-consanginuous German and Indonesian parents born at term was diagnosed with glutaric aciduria type I as a newborn by high-risk family screening (Patient #21). He is compound heterozygous for G185A and C176R resulting in complete loss of enzyme activity. This patient was admitted to hospital at 14 days of age and started on a low-lysine diet and carnitine supplementation. However, intermittently increased lysine intake and irregular carnitine supplementation were reported by his parents. In analogy to Case 1, transiently decreased carnitine levels and massive urinary excretion of glutaric and 3-hydroxyglutaric acid were found during these episodes ( Supplementary Fig. 1D ). He was never admitted to hospital for emergency treatment, and has not developed a movement disorder. He sat at 8 months, stood at 11 months and walked at 13 months of age. He is now 15 years of age and has passed the ninth class of general school (German secondary school). Psychological testing with HAWIK-III showed an average IQ (IQ at ages 13 and 15 years: 87 and 106).
Cranial MRI was performed at ages 0.5, 50, 131, 156 and 180 months. MRI findings consisted of the characteristically wide anterior temporal and sylvian CSF spaces and of atrophy, most pronounced in the cerebellum. Follow-up studies revealed evolving, confluent white matter abnormalities with involvement of the median corpus callosum (Fig. 4) .
Case 5: Late-onset disease with extensive white matter abnormalities A girl of non-consanginuous German parents was born at term and showed a normal development except for a transient motor delay (Patient #38). Despite several immunizations and febrile infectious diseases, she did not develop an acute encephalopathic crisis. She disliked protein-rich dairy products. At age 8.5 years, she became symptomatic with an episode of non-febrile severe nausea, recurrent vomiting, cephalgia and mild ataxia. No evidence for an infectious disease was found. Cranial MRI revealed extensive white matter abnormalities. Metabolic tests excluded peroxisomal or lysosomal disorders but demonstrated elevated urinary excretion of glutaric acid and 3-hydroxyglutaric acid (2100 and 110 mmol/mol creatinine) and low concentration of free plasma carnitine (3 mmol/l). Diagnosis was confirmed by enzyme and mutation analysis showing compound heterozygosity for R128Q and E414K and 1% of residual glutaryl-CoA dehydrogenase activity.
After the start of treatment symptoms gradually improved. Biochemical follow-up investigations showed a normalization of free plasma carnitine concentrations (45-67 mmol/l) and a moderate decrease in urinary glutaric acid excretion (1000-1200 mmol/mol creatinine). Neurological findings returned to normal, in particular there is no evidence for dystonia or chorea. Neuropsychological evaluation with HAWIK-III showed an average IQ of 96. MRI was repeated after 1 year (Fig. 5) and after 2 years of treatment. Despite clinical and biochemical improvement, extensive white matter abnormalities with involvement of the corpus callosum, T 2 hyperintensity of the thalamus, the tectal plate and periaqueductal zone and the dentate nucleus remained unchanged. Table 1 ) aged 5, 12 and 26 months (T 2 -weighted images). This patient presents with the characteristic aspect of frontotemporal hypoplasia: widening of anterior temporal and sylvian CSF spaces (unilateral short arrows). Deep grey matter involvement is atypical with T 2 hyperintensity initially of pallidum and dentate nucleus, subsequently also of thalamus and very discretely of the substantia nigra (unilateral arrowheads). With time the striatal signal increases, however, not exceeding that of cortex. With ongoing, though at 26 months as yet incomplete myelination of the anterior temporal and frontobasal subcortical white matter, symmetrical T 2 hyperintensity of the periventricular and lobar white matter and of the central tegmental tracts becomes more prominent (unilateral arrows).
Study population
The study included 68 cranial MRI scans from 38 patients (median age: 4.7 years, range: 1.4-69 years); basic information on study patients is summarized in Table 1 . Eighteen patients were diagnosed by selective screening due to the manifestation of neurologic symptoms following acute encephalopathic crises (n = 11; median age at diagnosis: 13.5 months), late-onset of neurological symptoms during adolescence or adulthood without preceding crises (n = 4; age at diagnosis: 103, 176, 258 and 785 months), or the diagnostic work-up of macrocephaly in asymptomatic patients (n = 3; age at diagnosis: 0.75, 1 and 24 months). Three patients were diagnosed by high-risk screening of families with a previously identified index case widened anterior temporal, sylvian and frontal CSF spaces normalize. The initial T 2 hyperintensity of the pallidum regresses; at 50 months pallidum and striatum are isointense and both slightly hypointense compared to cortex (unilateral short arrows). Myelination is delayed at 13 months [status of 8 months, incomplete myelination on T 1 inversion recovery images ( Supplementary Fig. 2 )] and at 24 months (incomplete myelination of anterior temporal subcortical white matter), but progressing and ultimately complete. White matter abnormalities evolve from strongly hyperintense cap-like regions around frontal and dorsal horns to more diffuse, confluent signal of the periventricular and lobar white matter (unilateral long arrows).
(age at diagnosis: 0.25, 1 and 28 months), while 17 patients were identified by newborn screening (median age at diagnosis: 0.25 months). The majority of patients (86%) showed a high-excreting biochemical phenotype with R402W (19% of alleles), A421V (10%) and E365K (9%) as the most frequent mutations.
All patients who were diagnosed after the manifestation of acute encephalopathic crises (11/11) presented with dystonia and motor disability (mild: 2/11 patients, moderate: 4/11 patients, severe: 3/11 patients and very severe: 2/11 patients). In three patients with suggested late-onset variant, mild-neurological symptoms (ataxia, cephalgia and hand tremor) occurred transiently but resolved completely after the initiation of treatment, whereas neurological symptoms improved only slightly in the fourth Patient (#16). All three patients, who were diagnosed due to macrocephaly were neurologically asymptomatic at diagnosis. One patient (#35) developed dystonia after delayed start of emergency treatment during gastroenteritis.
All patients identified by newborn screening (n = 17) or high-risk family screening (n = 3) were asymptomatic at diagnosis and the majority of them remained asymptomatic (17/20 patients). One of them (#34), in whom start of maintenance treatment was delayed for 7 months, developed mild dystonia without apparent crises (insidious-onset). Two pre-symptomatically diagnosed children (#1 and #36) suffered an encephalopathic crisis during gastroenteritis due to inadequate emergency treatment.
Spectrum of MRI abnormalities
Wide anterior temporal and sylvian CSF spaces was the most common MRI abnormality (37/38 patients) and was found in all Patients (8/8) who were examined in the newborn period. The extent varied between discrete widening due to underdevelopment of the inferior frontal gyrus, which could only be adequately appreciated on sagittal images (Fig. 6) , and massive widening easily observed on standard axial images. As hypoplasia of the inferior . MRIs document normalization of frontotemporal hypoplasia (unilateral long arrows) and disappearance of subependymal pseudocysts (short arrows) and cavum vergae. The term newborn has an immature pattern of gyration and myelination normally observed at 34-35 weeks postconceptional age with too shallow and less branched sulci (arrowheads) and slightly, diffusely T 2 hyperintense white matter. The adult gyral pattern is normally reached by 3 months, and on follow-up MRI gyration is adequate for age. Myelination at 24 months is still insufficient in the subcortical temporal and frontal white matter, but at 36 months myelination is complete and the MRI is now normal.
frontal gyrus was visible in all patients with sagittal images covering insula and opercula, it seems likely that the frontal lobe was always involved. We therefore, use the term frontotemporal hypoplasia. Interestingly, the initial widening of CSF spaces diminished (Figs 1 and 2 ) or even normalized (Fig. 3) . The frontotemporal and insular changes were similar to normal prenatal stages of frontotemporal development and opercularization.
Additional deviations from maturational changes of the developing brain, namely immature gyral pattern and myelination delay, were also common. A pattern of shallow sulci and white matter signal usually observed by 34-35 weeks of gestational age (Figs 3 and 6) was observed in four of the eight neonatally examined patients. Myelination delay was found in 21 of 38 patients and was most common between 20 and 28 months of age. Myelination delay was already present in four of the eight neonatally imaged patients, and was also found in Cases 1-4 (Figs 1-4) . Nevertheless, myelination was complete by the age of 4 years--except for one Patient (#35). second from left), and at 4, 11, 13 and 15 years of age (axial T 2 -weighted, sagittal T 1 -weighted). Frontotemporal hypoplasia (unilateral short arrows) does not resolve in this patient. There is atrophy, most pronounced in the cerebellum, and in addition, enlargement of the supravermian cistern and the cisterna magna (arrowheads). Between the ages of 4 and 11 years white matter abnormalities develop with strongly T 2 hyperintense changes of the median genu corporis callosi and the periventricular white matter and with less pronounced, diffuse hyperintensity of the supratentorial white matter (unilateral long arrows).
White matter signal abnormalities were also common (25/38 patients), the frequency increasing with age. They tended to be patchy or confluent in younger patients and were confluent in all patients examined after the age of 4 years. The periventricular white matter was involved in all patients and the signal alterations commonly extended into the deep white matter. Subcortical white matter was involved in seven patients, and corpus callosum in three patients. In the brainstem, abnormal, symmetrical T 2 hyperintensity of the central tegmental tracts was present in 14 patients.
Bilateral striatal abnormalities were found in 16 of 38 patients. Of note, none of the neonates had striatal changes inspite of one patient having already suffered from an encephalopathic crisis during the first week of life. Unexpectedly, abnormal signal of the pallidum was frequent, being present in 19 patients. Twelve patients presented with pallidal and striatal abnormalities, whereas seven patients had isolated pallidal changes. Other deep grey matter structures (Fig. 6) were much less often affected: the substantia nigra and dentate nuclei in seven patients and the thalamus in four patients.
Examples of striatal and extrastriatal MRI abnormalities are shown in Fig. 6 .
MRI abnormalities following acute encephalopathic crises
To identify brain regions that are particularly susceptible to cerebral injury during acute encephalopathic crises, we compared the frequency of specific MRI abnormalities between patients with and without crises using Fisher's exact test (Table 2 ). In analogy to previous studies (Brismar and Ozand, 1995; Strauss et al., 2007) , major changes after these crises were found in the basal ganglia, particularly affecting putamen and caudate (i.e. striatum), and less frequently the pallidum. Atrophy of affected basal ganglia structures resulted in the dilation of ventricles. Striatal abnormalities were also found in one patient with suggested insidious-onset variant, but not in four patients with late-onset type.
It is noteworthy that pallidal abnormalities were not only commonly found in combination with striatal abnormalities in dystonic patients with encephalopathic crises, but also as isolated findings in asymptomatic patients without encephalopathic crises (7/25 patients). In contrast to basal ganglia, the frequency of MRI changes in other brain regions did not differ between patients with and without encephalopathic crises--except for dilation of frontal CSF spaces, which showed a tendency to significance (Table 2) .
Age-dependent changes of MR abnormalities
To identify age-dependent abnormalities and to distinguish them from acute pathologic changes induced by acute encephalopathic crises, we calculated empirical cumulative distribution functions of defined brain regions in patients with and without known encephalopathic crises. Assuming that specific MRI abnormalities are due to the same underlying mechanism in different patients, this statistical analysis allowed us to estimate longitudinal changes in patient subgroups although timing and frequency of MRIs differed between individual study patients. In contrast to Figure 5 Follow-up MRI (A-D, F, H and I: T 2 -weighted; E, G and J: T 1 -weighted) of Case 5 (Patient #38) at the age of 9.5 years (i.e. 1 year after the diagnosis has been made and treatment has been started) demonstrates extensive white matter abnormalities persisting in the face of clinical and biochemical improvement since the initial MRI at age 8.5 years (not shown). As in Case 4 (Fig. 4) , T 2 hyperintensity is 'bimodal': strongly T 2 hyperintense white matter separated by a rim of near normal signal from less hyperintense more peripheral white matter (unilateral thin arrows). Note involvement of the median corpus callosum (short arrow), of thalamus and midbrain (long arrows), and the dentate nuclei (arrowheads). Fisher's exact test, which analyses differences in frequencies of MRI abnormalities (Table 2) , Peto and Peto test analyses differences in the time course of these MRI abnormalities among patients with and without encephalopathic crises. Peto and Peto test showed that striatal (putamen, caudate) MRI abnormalities differed between patients with and without encephalopathic crises, with time (Table 3 ). In contrast, the time course of pallidal MRI abnormalities occurring did not differ significantly between these groups suggesting that isolated pallidal abnormalities are not coupled to the manifestation of acute encephalopathic crises--in contrast to striatal lesions. Of course, pallidal changes were observed in a large proportion, in combination with striatal changes in patients with encephalopathy (12/19). However, an even larger proportion of patients with pallidal changes had concomitant white matter disease (17/19). Pallidal changes without white matter abnormalities were only observed in the context of striatal injury due to encephalopathic crises. Similar to white matter signal abnormalities, the frequency of pallidal abnormalities increased with the patient's age (Fig. 7) . The presence of pallidal changes correlated both with encephalopathy and white matter changes, possibly reflecting that the pallidum is a myelin-rich grey matter structure (Van der Knaap and Valk, 2005) .
Exemplied empirical cumulative distribution functions for MR abnormalities of cortex, putamen, pallidum and white matter in patients with and without acute encephalopathic crises are shown in Fig. 7 .
Association of MRI abnormalities in the basal ganglia and motor dysfunction
Having identified MRI changes in neurologically asymptomatic and symptomatic patients, we sought to identify those MRI changes associated with motor disability. For this purpose, we compared individual MRI findings with the neurological outcome evaluating morbidity score, handicap score and dystonia at the same time MRIs were taken. Severe motor disability, indicated by a high-morbidity score and handicap score, and the onset of dystonia was associated with MRI abnormalities in putamen, caudate, pallidum and, consequently, with dilation of ventricles (Table 4 , Fig. 8 ). In contrast, MRI abnormalities outside the basal ganglia were associated with a wide spectrum of neurological symptoms and thus did not allow an outline a clear-cut clinical phenotype. Only dilation of frontal CSF spaces showed a tendency to significance using handicap and morbidity score. As systematic testing of cognitive development was only performed in a subgroup of patients, the present study did not allow estimation of a graded quantitative impact of specific MRI abnormalities on cognitive dysfunction. Calculations of odds ratios and P-values were performed using Fisher's exact test (patients with versus w/o acute encephalopathic crises, AEC). Calculations were based on majority decisions of all three raters for individual patients and cranial MRI scans. Significant differences are highlighted using bold letters. Five patients with suggested alternative disease variants (one patient with insidious-onset; four patients with lateonset) were excluded from this analysis. However, an inclusion of these patients to group 'w/o AEC' showed similar results (data not shown). In addition, one patient with acute crisis was excluded in whom cranial MRI was performed before crisis only. AEC = acute encephalopathic crisis; CI = confidence interval; Inf = infinity.
Discussion
The major results of the present retrospective study are that: (i) MRI abnormalities of patients with glutaric aciduria type I are more complex and dynamic than previously recognized; (ii) some MRI abnormalities are related to age and appear to manifest acutely or progressively following a distinct time pattern; (iii) some MRI alterations represent a maturational delay resolving with age rather than a brain injury and (iv) striatal, but not extrastriatal, abnormalities are associated with motor dysfunction.
The striatum--the classic lesion localization
Previous neuroradiological studies have primarily focused on acute striatal abnormalities following acute encephalopathic crises (Brismar and Ozand, 1995; Desai et al., 2003; Elster, 2004 In combination with macrocephaly in infancy and abnormalities of the temporal and frontal lobes, acute striatal MRI abnormalities are highly suspicious for glutaric aciduria type I (Brismar and Ozand, 1995) . On MRI, acute striatal abnormalities are most conspicuous on diffusion-weighted MRI and they are characterized by restricted diffusion and T 2 hyperintensity (Elster, 2004; Santos et al., 2005; Strauss et al., 2007) . Recently, three stages of striatal injury were differentiated based on MRI changes, namely an acute stage with restricted diffusion presumably due to cytotoxic oedema, a subacute stage characterized by pseudo-normalization of apparent diffusion coefficient and swelling (vasogenic oedema) and a chronic atrophic stage with elevated apparent diffusion coefficient (Strauss et al., 2007) . In their study, an unexpectedly large number of Patients (6/9) with striatal injury of undetermined onset despite diagnosis and start of treatment during the newborn period were classified as insidious-onset type (Strauss et al., 2007) . Our study confirms that signal changes of the striatum are the most specific MRI abnormalities arising in infants with acute onset of motor dysfunction. However, it does not confirm a high frequency of the insidious-onset variant. Almost all study patients with striatal abnormalities presented with acute motor symptoms during an episode likely to precipitate acute encephalopathic crises, e.g. gastroenteritis or pneumonia. The one exception was a presymptomatically diagnosed patient with insidious-onset of motor symptoms, in whom the initiation of treatment was delayed for 7 months. An apparent limitation of our study is the lack of diffusion-weighted imaging and, consequently, the inability to assess diffusion properties of lesions. The detection of striatal abnormalities is nevertheless not hampered by this: acutely injured patients were examined at least 7 days after the injury, at a time when signal changes are already conspicuous on T 2 -weighted images. Moreover, all patients with insidious-onset of symptoms reported by Strauss et al. (2007) had not only elevated diffusion but also T 2 hyperintense lesions. In contrast, neither clinical signs of insidious-onset of striatal injury nor striatal T 2 hyperintensity and/or atrophy were found in our study patients in whom treatment was initiated immediately after the diagnosis of glutaric aciduria type I was suspected.
There is no generally accepted pathophysiological model for acute striatal injury in glutaric aciduria type I. Evidence is increasing that glutaric acid and 3-hydroxyglutaric acid heavily accumulate in the brain (Funk et al., 2005; Kü lkens et al., 2005; Sauer et al., 2006; Zinnanti et al., 2006; Keyser et al., 2008) inducing impairment of mitochondrial energy metabolism, and imbalance of excitatory and inhibitory neurotransmission (Kö lker et al., 2004; Sauer et al., 2005; Stellmer et al., 2007; Zinnanti et al., 2007) . These results favour a neurotoxicological model but cannot explain the age-dependent striatal vulnerability. To address this, various maturation-dependent aspects have been discussed including expression of glutamate and dopamine receptors, energy demand of the basal ganglia, cerebral lysine metabolism, myelination of the corticostriatal tracts, as well as unfavourable blood vessel geometry in the (lateral) striatum and high susceptibility of striatal medium spiny neurons (reviewed by Zinnanti et al., 2007) . This table presents the Peto and Peto modification of the Wilcoxon Gehan test for left-censored data. Calculations were based on majority decisions of all three raters for individual patients and cranial MRI scans. Significant differences are highlighted using bold letters. Five patients with suggested alternative disease variants (one patient with insidious-onset; four patients with late-onset) were excluded from this analysis. However, an inclusion of these patients to group 'w/o AEC' showed similar results (data not shown). In addition, one patient with acute crisis was excluded in whom cranial MRI was performed before crisis only. AEC = acute encephalopathic crisis.
Beyond the striatum--the spectrum of MRI abnormalities in glutaric aciduria type I
In contrast to the striatum, abnormalities of other deep grey matter nuclei have been described only sporadically in glutaric aciduria type I. These include the demonstration of isolated pallidal MRI abnormalities in a few asymptomatic patients Twomey et al., 2003) as well as T 2 hyperintensity of other nuclei including substantia nigra and dentate nuclei (Twomey et al., 2003) . For the present study, MRI was systematically evaluated for striatal and extrastriatal--grey and white matter--abnormalities. The results demonstrate that MRI abnormalities in extrastriatal brain regions are frequently found in patients with and without preceding encephalopathic crises. Previously unreported, brain maturation was retarded in half of the neonatally imaged term babies with glutaric aciduria type I, their gyral pattern and white matter signal corresponding to that usually observed at 34-35 weeks postconceptional age. As the 'adult' gyral pattern is usually reached by 3 months of age, only the myelination stage is an indicator of brain maturation in older infants and children. Again, delayed myelination was a common finding in children with glutaric aciduria type I (59%). The progression and--depending on the age--completion of myelination observable in patients with sequential MRI and the completed myelination in all patients older than 4 years of age, except one, Figure 7 Empirical cumulative distribution function of exemplified brain regions. Empirical cumulative distribution function of abnormalities in different brain regions and their differences between patients with and without acute encephalopathic crises were calculated (Table 3) to evaluate the age dependence of MRI abnormalities. Results for frontotemporal hypoplasia (A) putamen (B), globus pallidus (C) and white matter T 2 hyperintensity (D) were shown. Grey lines, without encephalopathy; black lines, with encephalopathy. Note the logarithmic scale for age. Statistical analysis was performed using Kruskal-Wallis test with Benjamini-Hochberg correction of P-values. Significant differences were highlighted using bold letters. Two patients with incomplete neuroscores were excluded. Using dystonia (0 = no, 1 = yes) or handicap score (0-4 pts) instead of morbidity score the same associations between MRI abnormalities and neurological disease were identified (data not shown). NA = not applicable. a Rating of MRI abnormalities was performed according to the previously defined evaluation protocol (Supplementary Table 1 ).
suggest that though delayed, brain maturation is ultimately completed. White matter abnormalities were common in both patient groups with (77%) and without (53%) encephalopathic crises, and did not correlate with encephalopathy, thereby suggesting that its development might not primarily depend on acute injury. White matter abnormalities were the major MRI finding in lateonset type. The neuropathological correlate of white matter abnormalities in glutaric aciduria type I is spongiform myelinopathy which seems to progress with age and has also been described in Gcdh-deficient mice (Chow et al., 1988; Soffer et al., 1992; Koeller et al., 2002; Kö lker et al., 2003) . Intramyelinic oedema with myelin vacuolation decreases extracellular space resulting in restricted diffusion. Conversely progressive damage and tissue loss and/or vasogenic oedema increase diffusion. The lack of diffusion-weighted images in this study, however, does not allow one to distinguish whether T 2 hyperintensity of white matter reflects intra-or extracellular water changes (Oguz et al., 2005; Strauss et al., 2007) . Previous neuroradiological studies in glutaric aciduria type I patients have observed both restricted (Bä hr et al., 2002; Oguz et al., 2005; Sonmez et al., 2007) and elevated diffusion (Strauss et al., 2007) .
Of extrastriatal grey matter, the pallidum was the most commonly affected structure (51%), whereas substantia nigra (16%), dentate nuclei (11%) and thalamus (5%) were less frequently involved. Of note, pallidal abnormalities occurred in two patterns, either in combination with striatal changes following encephalopathy or as isolated lesions in patients without encephalopathy. Regardless of encephalopathic crises, the presence of pallidal abnormalities correlated with the presence of white matter abnormalities. Since the pallidum--and similarly thalamus and brainstem reticular formation--represents a myelin-rich grey matter structure, it seems likely that it will be affected by changes of both grey and white matter components (Kracun et al., 1984 ; Figure 8 Association of MRI abnormalities in basal ganglia and motor dysfunction. Evaluation of motor disability using morbidity score (range: 0-4; 0 = asymptomatic; 4 = multiple morbidity) showed that the severity of motor disability was high in patients who had MRI abnormalities in dilated ventricles (A), putamen (B), caudate (C) and palladium (D). Using handicap score and manifestation of dystonia instead of morbidity score demonstrated the same associations to MRI abnormalities (not shown). A grey rectangle indicates the interquartile range, a filled circle the median and an open triangle the mean. Whiskers (black solid lines) extend 1.5 times from the first (25%) and third (75%) quantile, respectively. Outliers are marked by open circles.
Van der Knaap and Valk, 2005) . Pallidal MRI changes would result from acute grey matter injury during encephalopathic crises and/or from more slowly evolving, chronic white matter abnormalities and/or myelination delay. This is supported by the finding of a considerable decrease in myelin, but unaffected neuronal cell density of the globus pallidus in a post-mortem study (Chow et al., 1988) . It further raises the question whether (transient) pallidal abnormalities in patients without encephalopathic crises possibly reflect delayed myelination instead of irreversible pallidal grey matter injury.
Time pattern of striatal and extrastriatal MRI abnormalities--from foetal life to adulthood Four observations of the present study challenge our view on the neuropathogenesis of glutaric aciduria type I: (i) the high frequency of retarded brain maturation in neonates and infants; (ii) the regression of frontotemporal hypoplasia in pre-symptomatically diagnosed and treated patients; (iii) the completed myelination in virtually all children older than 4 years and (iv) the high frequency of white matter abnormalities increasing with age. These observations imply that in glutaric aciduria type I a chronically present, prenatally starting neurotoxicity may affect brain maturation as well as maintenance of white matter. This may be separate from the putative mechanism of acute striatal injury.
The hypothesis of glutaric aciduria type I prenatally affecting the brain is supported by the fact that widening of sylvian fissures and frontotemporal 'atrophy' are already present at the time of birth in preterm and term babies with glutaric aciduria type I and even during the last trimester of pregnancy (Forstner et al., 1999; Lin et al., 2002; Mellerio et al., 2008) . In the present study, all neonatally imaged patients had widening of anterior temporal and sylvian CSF spaces and half of them had an immature gyral pattern and white matter signal. Comparing the appearance of the anterior temporal lobe and the sylvian fissure in our patients with the normal development observed on MRI, the pattern of abnormality in glutaric aciduria type I patients is similar to different stages of normal development. Gyration and opercularization occur latest in the frontal and temporal areas, namely those affected in glutaric aciduria type I (Van der Knaap et al., 1996; Garel, 2004) . As regression of widened anterior temporal and sylvian CSF spaces occurred in neonatally diagnosed and treated patients, it seems likely that they presumably result from a potentially reversible (neurotoxic) arrest or delay of anterior temporal and opercular development.
With regard to putative pathomechanisms, it has been demonstrated that dicarboxylic acids such as glutaric acid and 3-hydroxyglutaric acid cannot easily permeate the blood-brain barrier (Hassel et al., 2002; Sauer et al., 2006) . Intracerebral trapping of glutaric acid and 3-hydroxyglutaric acid is the biochemical prerequisite for subsequent cerebral injury (Sauer et al., 2006; Zinnanti et al., 2006; Keyser et al., 2008) . This mechanism may become active as early as a functional blood-brain barrier is established already during foetal life. The expression of endothelial tight junctions and their adult-like distribution by midgestation suggest the establishment of a functional blood-brain barrier during the second half of fetal life (Virginto et al., 2004; Ballabh et al., 2005; Anstrom et al., 2007) . This is a time-point when the major waves of neuronal migration have ceased, and neuronal differentiation and cortex lamination begins. Therefore, a functional blood-brain barrier may be important to guarantee a constant environment and protected habitat of the differentiating neurons (Virginto et al., 2004) . Pathogenetically, we hypothesize that the establishment of a functional blood-brain barrier during the second half of pregnancy with consecutive accumulation of neurotoxic dicarboxylic acids in the brain compartment affects normal maturation in glutaric aciduria type I.
White matter changes in our patients consisted of myelination delay, which was already found in half of neonatally imaged patients, and of evolving T 2 hyperintensity of white matter. These were very often found in patients with and without acute crises and were statistically not linked with encephalopathic crises. Moreover, T 2 hyperintensity of white matter represents the characteristic MRI abnormality of late-onset disease (Bä hr et al., 2002; Kü lkens et al., 2005) . Whether this abnormality is induced during pre-or postnatal life (or both), is not yet known. Interestingly, immature oligodendroglial precursor cells can be injured by glutaric acid and 3-hydroxyglutaric acid (Gerstner et al., 2005) . It is tempting to speculate that from the time of a functional blood-brain barrier onwards, neurotoxic dicarboxylic acids not only interfere with gyration and opercularization, but also with maturation of white matter (manifesting as myelination delay) and maintenance of white matter (manifesting as T 2 white matter signal abnormality).
In conclusion, the present study highlights that striatal and extrastriatal MRI abnormalities in glutaric aciduria type I are dynamic and complex. We suggest that chronic neurotoxicity affects brain maturation and myelin maintenance and that its manifestation may be separate from the mechanisms of acute injury due to encephalopathic crises. This may have widespread consequences for the establishment of a unifying pathophysiological model and for therapeutic considerations, e.g. whether dietary treatment should be performed lifelong. A certain limitation of this study, however, is its retrospective design and the inclusion of patients from different metabolic centres and birth cohorts, which may cause bias. Therefore, a prospective follow-up study is required to further investigate the formal and causal aspects of striatal and extrastriatal abnormalities, their clinical relevance and prevention.
Supplementary material
Supplementary material is available at Brain online.
